Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
editorial
. 1978 Jun 17;1(6127):1571–1572. doi: 10.1136/bmj.1.6127.1571

Clinical use of 1-alpha-hydroxyvitamin D3.

PMCID: PMC1605415  PMID: 207382

Full text

PDF
1571

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balsan S., Garabedian M., Courtecuisse V., Guéris J., Dommergues J. P., Creignou L., le Denuff M. J., Rivron J. Long-term therapy with 1alpha-hydroxyvitamin D3 in children with 'pseudo-deficiency' rickets. Clin Endocrinol (Oxf) 1977 Dec;7 (Suppl):225s–230s. doi: 10.1111/j.1365-2265.1977.tb03386.x. [DOI] [PubMed] [Google Scholar]
  2. Boyle I. T., Fogelman I., Boyce B., Thomson J. E., Beastall G. H., McIntosh W. B., McLennan I. 1alpha-hydroxyvitamin D3 in primary hyperparathyroidism. Clin Endocrinol (Oxf) 1977 Dec;7 (Suppl):215s–222s. doi: 10.1111/j.1365-2265.1977.tb03384.x. [DOI] [PubMed] [Google Scholar]
  3. Brickman A. S., Coburn J. W., Friedman G. R., Okamura W. H., Massry S. G., Norman A. W. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man. J Clin Invest. 1976 Jun;57(6):1540–1547. doi: 10.1172/JCI108424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Coburn J. W., Hartenbower D. L., Norman A. W. Metabolism and action of the hormone vitamin D. Its relation to diseases of calcium homeostasis. West J Med. 1974 Jul;121(1):22–44. [PMC free article] [PubMed] [Google Scholar]
  5. Fraser D., Scriver C. R. Familial forms of vitamin D-resistant rickets revisited. X-linked hypophosphatemia and autosomal recessive vitamin D dependency. Am J Clin Nutr. 1976 Nov;29(11):1315–1329. doi: 10.1093/ajcn/29.11.1315. [DOI] [PubMed] [Google Scholar]
  6. Haussler M. R., McCain T. A. Basic and clinical concepts related to vitamin D metabolism and action (first of two parts). N Engl J Med. 1977 Nov 3;297(18):974–983. doi: 10.1056/NEJM197711032971804. [DOI] [PubMed] [Google Scholar]
  7. Kanis J. A., Russell R. G. Rate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its 1alpha-hydroxylated derivatives. Br Med J. 1977 Jan 8;1(6053):78–81. doi: 10.1136/bmj.1.6053.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kanis J. A., Russell R. G., Smith R. Physiological and therapeutic differences between vitamin D, its metabolites and analogues. Clin Endocrinol (Oxf) 1977 Dec;7 (Suppl):191s–201s. doi: 10.1111/j.1365-2265.1977.tb03381.x. [DOI] [PubMed] [Google Scholar]
  9. Marshall D. H., Nordin B. E. The effect of 1alpha-hydroxyvitamin D3 with and without oestrogens on calcium balance in post-menopausal women. Clin Endocrinol (Oxf) 1977 Dec;7 (Suppl):159s–168s. doi: 10.1111/j.1365-2265.1977.tb03377.x. [DOI] [PubMed] [Google Scholar]
  10. Neer R. M., Holick M. F., DeLuca H. F., Potts J. T., Jr Effects of 1alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 on calcium and phosphorus metabolism in hypoparathyroidism. Metabolism. 1975 Dec;24(12):1403–1413. doi: 10.1016/0026-0495(75)90055-4. [DOI] [PubMed] [Google Scholar]
  11. Peacock M., Aaron J. E., Walker G. S., Davison A. M. Bone disease and hyperparathyroidism in chronic renal failure: the effect of 1alpha-hydroxyvitamin D3. Clin Endocrinol (Oxf) 1977 Dec;7 (Suppl):73s–81s. doi: 10.1111/j.1365-2265.1977.tb03365.x. [DOI] [PubMed] [Google Scholar]
  12. Pierides A. M., Ellis H. A., Simpson W., Dewar J. H., Ward M. K., Kerr D. N. Variable response to long-term 1alpha-hydroxycholecalciferol in haemodialysis osteodystrophy. Lancet. 1976 May 22;1(7969):1092–1095. doi: 10.1016/s0140-6736(76)90061-1. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES